Literature DB >> 27227756

Neuroendocrine liver metastases: Value of apparent diffusion coefficient and enhancement ratios for characterization of histopathologic grade.

Cecilia Besa1,2, Stephen Ward3, Yong Cui2,4, Guido Jajamovich2, Michelle Kim5, Bachir Taouli1,2.   

Abstract

PURPOSE: To assess the value of apparent diffusion coefficient (ADC) measured with diffusion-weighted imaging (DWI) and enhancement ratios (ER) measured with contrast-enhanced T1-weighted imaging (CE-T1WI) for the characterization of histopathologic tumor grade of neuroendocrine tumor liver metastases (NETLM).
MATERIALS AND METHODS: Twenty-two patients with pathology-proven NETLM and pretreatment 1.5 Tesla (T) and 3T MRI including DWI were included in this Institutional Review Board-approved retrospective study. ADC histogram parameters, including mean, minimum (min), skewness, and kurtosis as well as ER, were computed for all lesions. Tumor grading was based on the World Health Organization 2010 classification. Kruskal-Wallis and Mann-Whitney test were used to assess for differences in ADC and ER between different tumor grades. MRI parameters were correlated with pathologic findings using Spearman correlation test. Receiver operating characteristic analysis was performed to determine optimum thresholds for predicting tumor grade.
RESULTS: Forty-eight NETLM (mean size 3.5 cm) were analyzed with the following grade distribution: G1 (n = 25), G2 (n = 16), and G3 (n = 7). ADC-mean (×10-3 mm2 /s) of G3 tumors (0.87 ± 0.43) was significantly lower than that of G1 (1.47 ± 0.63) and G2 (1.27 ± 0.63; P = 0.042). A weak significant negative correlation was observed between ADC and tumor grade (ADC-mean: r = -0.33, P = 0.02; ADC-min: r = -0.37, P = 0.01) and Ki-67 (ADC-mean: r = -0.31, P = 0.03; ADC-min: r = -0.39, P = 0.007). AUROC, sensitivity and specificity of ADC-mean/ADC-min/ER (measured at the early arterial phase) for differentiation of G3 versus G1-G2 were 0.80/0.76/0.67, 100%/50%/70%, and 68.4%/84.2%/66.6%, respectively.
CONCLUSION: ADC is a promising marker for characterization of histopathologic grade of NETLM. These results should be confirmed in a prospective study. J. Magn. Reson. Imaging 2016;44:1432-1441.
© 2016 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  contrast enhancement; diffusion weighted imaging; magnetic resonance imaging; neuroendocrine tumors

Mesh:

Year:  2016        PMID: 27227756     DOI: 10.1002/jmri.25320

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  11 in total

1.  CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.

Authors:  Dongsheng Gu; Yabin Hu; Hui Ding; Jingwei Wei; Ke Chen; Hao Liu; Mengsu Zeng; Jie Tian
Journal:  Eur Radiol       Date:  2019-06-21       Impact factor: 5.315

2.  Hepatic neuroendocrine tumour: Apparent diffusion coefficient as a potential marker of prognosis associated with tumour grade and overall survival.

Authors:  Ji Hye Min; Tae Wook Kang; Young Kon Kim; Seong Hyun Kim; Kyung Sook Shin; Jeong Eun Lee; Sang Yun Ha; Insuk Sohn
Journal:  Eur Radiol       Date:  2018-01-24       Impact factor: 5.315

Review 3.  Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies.

Authors:  Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal:  Expert Rev Anticancer Ther       Date:  2018-07-17       Impact factor: 4.512

4.  Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects.

Authors:  Sonya Park; Ashwin Singh Parihar; Lisa Bodei; Thomas A Hope; Nadine Mallak; Corina Millo; Kalpna Prasad; Don Wilson; Katherine Zukotynski; Erik Mittra
Journal:  J Nucl Med       Date:  2021-07-22       Impact factor: 11.082

5.  3D analysis of apparent diffusion coefficient histograms in hepatocellular carcinoma: correlation with histological grade.

Authors:  Tomohisa Moriya; Kazuhiro Saito; Yu Tajima; Taiyo L Harada; Yoichi Araki; Katsutoshi Sugimoto; Koichi Tokuuye
Journal:  Cancer Imaging       Date:  2017-01-05       Impact factor: 3.909

6.  Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 2: ADCmin.

Authors:  Alexey Surov; Hans Jonas Meyer; Andreas Wienke
Journal:  Oncotarget       Date:  2018-01-04

7.  Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 1: ADCmean.

Authors:  Alexey Surov; Hans Jonas Meyer; Andreas Wienke
Journal:  Oncotarget       Date:  2017-08-24

8.  Dynamic enhanced CT: is there a difference between liver metastases of gastroenteropancreatic neuroendocrine tumor and adenocarcinoma.

Authors:  Yong Cui; Zhong-Wu Li; Xiao-Ting Li; Shun-Yu Gao; Ying Li; Jie Li; Hui-Ci Zhu; Lei Tang; Kun Cao; Ying-Shi Sun
Journal:  Oncotarget       Date:  2017-11-20

9.  Correlation Between Apparent Diffusion Coefficient Value on MRI and Histopathologic WHO Grades of Neuroendocrine Tumors.

Authors:  Wouter Mebis; Annemiek Snoeckx; Bob Corthouts; Haroun El Addouli; Simon Nicolay; Astrid Van Hoyweghen; Maarten Spinhoven; Bart Op de Beeck
Journal:  J Belg Soc Radiol       Date:  2020-01-30       Impact factor: 1.894

10.  Utility of CT in differentiating liver metastases of well-differentiated gastroenteropancreatic neuroendocrine neoplasms from poorly-differentiated neuroendocrine neoplasms.

Authors:  Yong Cui; Xiaoting Li; Shunyu Gao; Zhongwu Li; Yanling Li; Ming Lu; Yingshi Sun
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.